SEC Form 4 · accession 0002048467-26-000007
Beta Bionics, Inc. · BBNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christy Jones
Director
Period of report
Sep 22, 2026
Accepted (ET)
Sep 23, 2026 · 5:40 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001674632
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 22, 2026 | S | 6,430 | $23.00 | D | 19,564 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on February 19, 2026.